Novo Nordisk
NVO
#96
Rank
ยฃ147.93 B
Marketcap
ยฃ33.46
Share price
-0.46%
Change (1 day)
-20.57%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Market capitalization of Novo Nordisk (NVO)

Market cap: ยฃ147.93 Billion

As of September 2026 Novo Nordisk has a market cap of ยฃ147.93 Billion. This makes Novo Nordisk the world's 96th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novo Nordisk from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ147.93 B-14.44%
2025ยฃ172.89 B-43.51%
2024ยฃ306.04 B-15.46%
2023ยฃ362.01 B43.83%
2022ยฃ251.69 B33.2%
2021ยฃ188.96 B57.95%
2020ยฃ119.63 B12.76%
2019ยฃ106.09 B20.45%
2018ยฃ88.08 B-9.22%
2017ยฃ97.02 B27.13%
2016ยฃ76.32 B-25.74%
2015ยฃ102.77 B42.07%
2014ยฃ72.33 B17.92%
2013ยฃ61.34 B9%
2012ยฃ56.28 B31.14%
2011ยฃ42.91 B-1.91%
2010ยฃ43.75 B74.9%
2009ยฃ25.01 B12.53%
2008ยฃ22.23 B5.24%
2007ยฃ21.12 B55.95%
2006ยฃ13.54 B28.21%
2005ยฃ10.56 B12.55%
2004ยฃ9.38 B18.72%
2003ยฃ7.90 B25.99%
2002ยฃ6.27 B-34.55%
2001ยฃ9.58 B15.77%
2000ยฃ8.28 B45.99%
1999ยฃ5.67 B-2.15%
1998ยฃ5.79 B-12%
1997ยฃ6.58 B60.88%
1996ยฃ4.09 B

End of Day market cap according to different sources

On Sep 1st, 2026 the market cap of Novo Nordisk was reported to be:

ยฃ148.21 Billion
by Nasdaq info icon info icon
ยฃ147.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
ยฃ120.67 B-18.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ767.11 B 418.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ78.84 B-46.70%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
ยฃ101.37 B-31.47%๐Ÿ‡บ๐Ÿ‡ธ USA